Jakob Knudsen
Algemeen Directeur bij VIROGATES A/S
Vermogen: 116 241 $ op 30-04-2024
Actieve functies van Jakob Knudsen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Bestuurslid | 01-04-2017 | - |
| Independent Dir/Board Member | 01-04-2017 | - | |
| VIROGATES A/S | Algemeen Directeur | 01-04-2011 | - |
| Investor Relations Contact | - | - | |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Directeur/Bestuurslid | - | - |
| Independent Dir/Board Member | - | - | |
| P.V. Fonden | Directeur/Bestuurslid | - | - |
| Ingeniørsystem A/S | Directeur/Bestuurslid | - | - |
| Jakob Knudsen Enkeltmandsvirksomhed | Directeur/Bestuurslid | - | - |
Loopbaan van Jakob Knudsen
Eerdere bekende functies van Jakob Knudsen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Financieel Directeur/CFO | 01-02-2008 | 01-04-2011 |
| ALK-ABELLÓ A/S | Corporate Officer/Principal | 01-09-1999 | 01-02-2008 |
Opleiding van Jakob Knudsen
| Imperial College London | Masters Business Admin |
| University of Copenhagen | Graduate Degree |
Statistieken
Internationaal
| Denemarken | 9 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ALK-ABELLÓ A/S | Health Technology |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| VIROGATES A/S | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
| P.V. Fonden | |
| Ingeniørsystem A/S | |
| Jakob Knudsen Enkeltmandsvirksomhed |
- Beurs
- Insiders
- Jakob Knudsen
- Ervaring